Total planned funding: $376,372,427
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Namibia | $376,372,427 |
Organizational Types
| NGO | $100,545,906 |
| Private Contractor | $69,844,559 |
| Host Country Government Agency | $62,641,409 |
| Own Agency | $55,485,420 |
| Unknown | $32,819,704 |
| University | $30,304,898 |
| Implementing Agency | $8,655,552 |
| Parastatal | $5,600,665 |
| FBO | $4,170,045 |
| Other USG Agency | $3,514,269 |
| Multi-lateral Agency | $2,790,000 |
Program Areas
| Treatment | $95,306,687 |
| Prevention | $79,106,130 |
| Care | $75,038,342 |
| Governance and Systems | $56,462,425 |
| Management and Operations | $43,439,091 |
| Testing | $27,019,752 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $76,906,772 |
| HVMS: Management and Operations | $43,439,091 |
| HKID: Care: Orphans and Vulnerable Children | $28,959,804 |
| OHSS: Health Systems Strengthening | $28,798,299 |
| HVCT: Testing: HIV Testing and Counseling | $27,019,752 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $25,713,304 |
| HBHC: Care: Adult Care and Support | $25,362,720 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $22,896,792 |
| HVSI: Strategic Information | $21,198,298 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $15,162,422 |
| HVTB: Care: TB/HIV | $13,539,335 |
| HTXD: Treatment: ARV Drugs | $9,749,571 |
| PDTX: Treatment: Pediatric Treatment | $8,650,344 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $8,497,123 |
| PDCS: Care: Pediatric Care and Support | $7,176,483 |
| HLAB: Laboratory Infrastructure | $6,465,828 |
| HMBL: Biomedical Prevention: Blood Safety | $3,857,458 |
| HMIN: Biomedical Prevention: Injection Safety | $2,979,031 |
Top Partner Programs
USG Aggregated Agencies:
$45,348,231
Countries/Regions
Potentia Namibia:
$40,226,364
Countries/Regions
Not Available:
$32,902,704
Countries/Regions